Inhibition of p38-MAPK alters SRC coactivation and estrogen receptor phosphorylation

Anti-proliferative effects of the novel ceramide analog (S)-2-(benzylideneamino)-3-hydroxy-N-tetrade-cylpropanamide in chemoresistant cancer

(2012) James W. Antoon et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2

(2011) James W. Antoon et al.   CANCER BIOLOGY & THERAPY

Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer

(2011) J. W. Antoon et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Mitogen-activated protein kinase kinase kinase 1 (MAP3K1) integrates developmental signals for eyelid closure

(2011) E. Geh et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Mechanisms and functions of p38 MAPK signalling

(2010) Ana Cuadrado et al.   BIOCHEMICAL JOURNAL

Novel d-erythro N-octanoyl sphingosine analogs as chemo- and endocrine-resistant breast cancer therapeutics

(2010) James W. Antoon et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Antiestrogenic Effects of the Novel Sphingosine Kinase-2 Inhibitor ABC294640

(2010) James W. Antoon et al.   ENDOCRINOLOGY

p38 Mitogen-activated protein kinase-dependent regulation of SRC-3 and involvement in retinoic acid receptor α signaling in embryonic cortical neurons

(2009) Zhi Chai et al.   IUBMB LIFE

Design, Synthesis, and Biological Activity of a Family of Novel Ceramide Analogues in Chemoresistant Breast Cancer Cells

(2009) James W. Antoon et al.   JOURNAL OF MEDICINAL CHEMISTRY

The nuclear appearance of ERK1/2 and p38 determines the sequential induction of ATF2-Thr71 and ATF2-Thr69 phosphorylation by serum in JNK-deficient cells

(2009) Bart Baan et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Organochlorine-mediated potentiation of the general coactivator p300 through p38 mitogen-activated protein kinase

(2008) M. R. Bratton et al.   CARCINOGENESIS